This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Innovations in Recombinant Protein Production: The Contributions of David Henry Kirkley
Introduction: David Henry Kirkley, an esteemed inventor based in East Syracuse, NY, has made significant strides in the field of biotechnology. With a total of five patents to his name, he has been a key player in developing technologies that enhance the production and purification of vital recombinant proteins. His work is crucial in advancing therapeutic applications in medicine.
Latest Patents: Among his noteworthy contributions, Kirkley has focused on compositions and methods for producing a recombinant protein known as CTLA4-Ig. His latest patents detail innovative methodologies allowing mammalian cells to produce CTLA4-Ig and its variants efficiently. These inventions encompass not only the production processes but also include compositions and formulations of CTLA4-Ig, as well as purification methods to ensure the quality and efficacy of this recombinant protein.
Career Highlights: David Henry Kirkley has established a successful career within the prestigious Bristol-Myers Squibb Company, where he collaborates with talented professionals to push the boundaries of biotechnology. His expertise extends to the development of cutting-edge methods that facilitate the mass production of critical therapeutic proteins, underscoring his role as an influential figure in his field.
Collaborations: Throughout his career, Kirkley has worked alongside accomplished colleagues, including Kirk J. Leister and Eugene J. Schaefer. These collaborations enrich the innovative environment in which they operate, fostering the development of groundbreaking solutions in protein science and biotechnology.
Conclusion: David Henry Kirkley's contributions to the world of biotechnology, particularly in the realm of recombinant protein production, represent significant advancements in the field. His patents serve as a testament to his innovative spirit and dedication to improving therapeutic options, ultimately benefiting the medical community and patients alike.